NEW YORK, Jan. 31 - Lion Bioscience has tied up its acquisition of NetGenics, the company said on Wednesday.
The acquisition, first announced two weeks ago, makes NetGenics a part of Lion's US-based operations.
Manuel Glynias, NetGenics' president and CEO, will become senior vice president for strategic planning at Lion, and Michael Dickson, who was chief technology officer at NetGenics, will become a the senior principal architect at Lion. Both men "will initially focus on the integration of NetGenics' DiscoveryCenter software" into Lion's product portfolio, Lion said in a statement.
A spokeswoman for Lion's US headquarters, in Cambridge, Mass., said that the rest of NetGenics' employees will be spared their jobs.